Ahmed Bargheet

Doctoral research fellow

Job description

I am a link in a chain that focuses on fighting antibiotic resistance. So, without exaggeration, we are working for saving the world from AMR danger that is projected to kill 10 million people by 2050.

Current position

  • Ph.D. fellow, Department of Medical Biology, The Arctic University of Norway
  • Member of Research Group for Host-Microbe interaction (HMI)
  • Member of Pediatric Research Group 

My main work is bioinformatics, however, because of my background, I am fairly competent in the following skills:

  • Gut Microbiota, Antibiotic Resistance & Mobilome
  • Shotgun & Functional metagenomics
  • Multi-omics
  • Meta-analysis Study
  • Linux system
  • High-performance computing (HPC) system
  • R programming language and Shiny R
  • Bash & SLURM scripting
  • MySQL
  • Statistical analysis & Machine learning
  • Nucleic acid extraction
  • PCR and RT-PCR
  • Gel electrophoresis
  • Western Blotting


  • MSc Applied Biotechnology, Inland Norway University of Applied Sciences
  • Bc Pharmacy, Al-Azhar University in Cairo



  • Achal Dhariwal, Lars Christian Haugli Bråten, Kjersti Sturød, Gabriela Salvadori Da Silva, Ahmed Bargheet, Heidi Aarø Åmdal et al.:
    Differential response to prolonged amoxicillin treatment: long-term resilience of the microbiome versus long-lasting perturbations in the gut resistome
    Gut microbes 2023 DOI
  • Ahmed Bargheet, Claus Andreas Klingenberg, Eirin Esaiassen, Erik Hjerde, Jorunn Pauline Cavanagh, Johan Bengtsson-Palme et al.:
    Development of early life gut resistome and mobilome across gestational ages and microbiota-modifying treatments
    EBioMedicine 2023 ARKIV / DOI
  • Adriana Dorota Osinska, Ahmed Bargheet, Agnieszka Cuprys, Ida Fløystad, Hans Geir Eiken, Kenneth William Lindstedt et al.:
    Wastewater Chronicles: Comprehensive ANalysis of Antibiotic Resistance in Wastewater
  • Ahmed Bargheet, Veronika K. Pettersen :
    How beneficial bacteria can help premature babies thrive
    sciencenorway.no 16. June 2023 FULLTEKST
  • Ole Gunnar Onsøien, Jan Fredrik Frantzen, Claus Andreas Klingenberg, Ahmed Bargheet, Veronika K. Pettersen :
    Ny norsk studie om probiotika og premature fødsler
    Dagens medisin 2023 FULLTEKST
  • Jan Fredrik Frantzen, Ahmed Bargheet, Veronika K. Pettersen :
    Probiotics create order in preterm babies’ gut, and fight antimicrobial resistance
    uit.no/nyheter 2023 FULLTEKST

  • The 50 latest publications is shown on this page. See all publications in Cristin here →

    Research interests

    My previous work

     I worked on the evaluation of the impact of long-term amoxicillin administration on the human resistome using functional metagenomics

    Five novel genes were identified at which one of them could resist the PenicillinG at a MIC higher than the breakpoint reported by EUCAST by 300 times.

    Current work

    Funded by Helse Nord RHF

    • First project (PINGU)

    This is an observational, longitudinal study that included 31 probiotic-supplemented extremely preterm infants, 35 very preterm infants not given probiotics, and 10 healthy full-term control infants. This study will identify the impact of probiotics and antibiotic therapy on infants gut microbiota, resistome, and mobilome.

    • Second project (Meta-analysis study)

    This study represents a comprehensive meta-analysis incorporating data from 14 previously published cohort studies, with the objective of elucidating the influence of various factors - including antibiotic exposure, gestational age, mode of delivery, type of milk, and geographic location - on the gut microbiota, resistome, and mobilome of infants. Furthermore, this research endeavors to identify the specific bacterial species that may predominantly act as reservoirs for antibiotic resistance genes, thereby contributing to our understanding of microbial ecology and antibiotic resistance dissemination.

    • Third project (ProRIDE)

    This is a randomized clinical trial co-led by the Pediatric Research group in Tromsø (UiT / UNN), which investigates the impact of probiotic therapy in Tanzanian infants and its potential to prevent infections by ESBL-producing Enterobacterales.

    • Fourth project (IMPALE) 

    This is a pilot study of newborns with suspected signs of infection during the 1st week of life leading to antibiotic therapy. The purpose of the study is to report changes in fecal microbial composition in relation to antibiotic usage and integrate the result with a metabolomics study.


    Member of research group

    Member of project